CINECA IRIS Institutional Research Information System

Molecular prediction of durable remission after first-line fludarabinecyclophosphamide-rituximab in chronic lymphocytic leukemia

COSCIA, Marta;MASSAIA, Massimo;
2015-01-01
2015
BLOOD
126
16
1921
1924
http://www.bloodjournal.org/content/bloodjournal/126/16/1921.full.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743433/
Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 17; Cyclophosphamide; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Middle Aged; Rituximab; Survival Rate; Vidarabine; Chromosome Deletion; Leukemia, Lymphocytic, Chronic, B-Cell; Smith-Magenis Syndrome; Hematology; Biochemistry; Cell Biology; Immunology; Medicine (all)
Rossi, Davide; Terzi-Di-Bergamo, Lodovico; De Paoli, Lorenzo; Cerri, Michaela; Ghilardi, Guido; Chiarenza, Annalisa; Bulian, Pietro; Visco, Carlo; Mau...espandi
03A-Articolo su Rivista
File in questo prodotto:
File Dimensione Formato  
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia_2015.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 734.89 kB
Formato Adobe PDF
  Visualizza/Apri   Richiedi una copia
734.89 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1552529
Citazioni
  • ???jsp.display-item.citation.pmc??? 84
  • Scopus 188
  • ???jsp.display-item.citation.isi??? 184
social impact